Red cell N5-methyltetrahydrofolate concentrations and C677T methylenetetrahydrofolate reductase genotype in patients with stroke

Journal of Clinical Pathology

Volumn 57, Issue 1, 2004, Pages 54-57

  Icke, G C ^a   Dennis, M ^b   Sjollema, S ^a   Nicol, D J ^a   Eikelboom, J W ^a,c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; CYSTEINE; FOLIC ACID; HOMOCYSTEINE; MULTIVITAMIN; PYRIDOXINE; THREONINE; 5-METHYLTETRAHYDROFOLATE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); TETRAHYDROFOLIC ACID DERIVATIVE; VITAMIN;

ACUTE DISEASE; AMINO ACID SUBSTITUTION; ANALYZER; ARTICLE; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOCUMENTATION; ENTEROCOCCUS FAECALIS; ERYTHROCYTE; FOLIC ACID BLOOD LEVEL; GENOTYPE; HOSPITAL; HUMAN; HUMAN CELL; LACTOBACILLUS CASEI; MAJOR CLINICAL STUDY; MEASUREMENT; PRIORITY JOURNAL; SERUM; STROKE; VITAMIN SUPPLEMENTATION; ANALYSIS OF VARIANCE; BLOOD; CEREBROVASCULAR ACCIDENT; CHEMISTRY; DIET SUPPLEMENTATION; ENZYMOLOGY; GENETICS;

ACUTE DISEASE; ANALYSIS OF VARIANCE; CEREBROVASCULAR ACCIDENT; DIETARY SUPPLEMENTS; ERYTHROCYTES; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); TETRAHYDROFOLATES; VITAMINS;

EID: 0347125123     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.57.1.54     Document Type: Article

References (23)

1. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999;28:407-13.
2. Eikelboom JW, Lonn E, Genest J Jr, et al. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999;131:363-75.
3. Finkelstein JD. The metabolism of homocysteine: pathways and regulation. Eur J Pediatr 1998;157(suppl 2):S40-4.
4. Eikelboom JW, Hankey GJ, Anand SS, et al. Association between high homocysteine and ischemic stroke due to large and small artery disease but no other etiological subtypes of ischemic stroke. Stroke 2000;31:1069-75.
5. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
6. Klerk M, Verhoef P, Clarke R, and the MTHFR Studies Collaboration Group, et al. MTHFR 677C→T polymorphism and risk of coronary heart disease. A meta-analysis. JAMA 2002;288:2023-31.
7. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202-8.
8. Molloy AM, Daly S, Mills JL, et al. Thermolabile voriant af 5,10methylenetetrahydrofolate reductase associated with low red cell folates; implications for folote intake recommendations. Lancet 1997;349:1591-3.
9. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. Mutated methylenehydrofolate reductose as a risk factor for spina bifido. Lancet 1995;346:1070-1.
10. Engbersen AMT, Franken DG, Boers GH, et al. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinaemia. Am J Hum Genet 1995;56:142-50.
11. Kang SS, Wong PW. 1996. Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia. Atherosclerosis 1996;119:135-8.
12. Kluijtmans LA, van den Heuvel LP, Boers GH, et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996;58:35-41.
13. Molloy AM, Mills JL, Kirke PN, et al. Whole-blood folate values in subjects with different methylenetetrahydrofolate reductase genotypes: differences between the radioassay and microbiological assays. Clin Chem 1998;44:186-8.
14. Quere I, Wutschert R, Zittoun J, et al. Association of red-blood methylfolate but not plasma folate with C677T MTHFR polymorphism in venous thromboembolic disease. Thromb Haemost 1980;80:707-9.
15. Davis RE, Nicol DJ, Kelly A. An automated method for the measurement of folate activity. J Clin Pathol 1970;23:47-53.
16. Chanarin I. The megaloblastic anaemias, 3rd ed. London: Blackwell Scientific Publications, 1990.
17. Anderson BB, Sourial NA. The assay of serum cobalamin by Euglena gracilis. In: Hall CA, ed. Methods in haematology. The Cobalamins, Vol. 10, 1983:51-64.
18. Davis RE, Smith BK, Curnow DH. An automated method for the assay of serum pyridoxal. J Clin Pathol 1973;26:871-4.
19. Wright AJ, Finglas PM, Southon S. Erythrocyte folate analysis: saponin added during lysis of whole blood can increase apparent folate concentrations depending on haemolysate pH. Clin Chem 2000;46:1978-86.
20. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-13.
21. Markus HS, Ali N, Swaminathan R, et al. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine and ischemic cerebrovascular disease. Stroke 1997;28:1739-43.
22. Kluijtmans LA, Whitehead AS. Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease: evidence that all three MTHFR C677T genotypes confer different levels of risk. Eur Heart J 2001;22:271-3.
23. Usui M, Matsuoka H, Miyazaki H, et al. Endothelial dysfunction by acute hyperhomocyst(e)inaemia: restoration by folic acid. Clin Sci (Lond) 1999;96:235-9.